Novel Therapy

Photos »

  /  
Related News »
Researchers have found that a novel treatment that combines cognitive behavior therapy (CBT) with soothing sounds of the sea is much more effective in treating tinnitus than existing available therapies for reducing symptoms of this common ...
May 24, 2012 at 23:57 | Source: Medical Daily
TTFields therapy is the first entirely novel cancer treatment modality to be introduced for recurrent glioblastoma patients since the introduction of chemotherapy. The website ensures that patients, their caregivers and health care professionals ...
May 13, 2012 at 23:56 | Source: Marketwatch
When the San Francisco Bay Guardian published "Hiding Out" in the late '90s, I never imagined that an article about gay teens who escaped from reparative-therapy "schools" would eventually evolve into my first novel or a documentary produced by George ...
May 24, 2012 at 04:38 | Source: Huffington Post
The CARILLON system is a novel therapy for treating heart patients suffering from functional mitral regurgitation (FMR) and has CE Mark approval, enabling commercialization in Europe. TITAN (Transcatheter Implantation of CARILLON Mitral ...
May 21, 2012 at 17:06 | Source: StreetInsider.com
HONG KONG May 24 (Reuters) - Sanofi-Aventis plans to begin testing a novel compound that is designed to starve ... Viehbacher in an interview in Hong Kong. The personalised therapy is tailored for a certain type of liver cancer patients who ...
May 24, 2012 at 09:02 | Source: Reuters
Galectin Therapeutics Inc announced that the first patient has been dosed in a Phase 1/2 trial evaluating the safety and efficacy of a treatment combination for the treatment of advanced metastatic melanoma. The trial, being conducted in collaboration with ...
May 15, 2012 at 16:37 | Source: Reuters
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company is rebranding its leading MS therapy with the new name Tcelna TM. The product ...
May 21, 2012 at 16:15 | Source: News-Medical.Net
Hong Kong - Drug company Sanofi-Aventis plans to begin testing a novel compound that is designed to starve ... Viehbacher said in an interview in Hong Kong. The personalised therapy is tailored for a certain type of liver cancer patients who ...
May 24, 2012 at 14:39 | Source: Beeld
Results of the first randomized controlled trial to compare a novel cancer treatment modality delivering Tumor Treating Fields (TTFields) therapy versus chemotherapy in patients with recurrent glioblastoma (GBM) were published in the European ...
May 21, 2012 at 15:54 | Source: News-Medical.Net
We are very excited about this partnership and are looking forward to progressing the development of SIG990 as a novel therapy for the treatment of rosacea." About Argyle Therapeutics Argyle was formed and founded in December 2010 and is a spin-out of Signum Biosciences.
May 23, 2012 at 16:13 | Source: ad-hoc-news.de